Medicare Enrolled

Dr. Mahakit Inklab, MD

Hematology & Oncology · Sunnyside, WA
Low-engagement
1013 E. EDISON AVE, Sunnyside, WA 98944
5098371587
In practice since 2007 (19 years)
NPI: 1124229869 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Inklab from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Inklab? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Inklab

Dr. Mahakit Inklab is a hematology & oncology specialist in Sunnyside, WA, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Inklab received a total of $4,351 from 51 pharmaceutical and/or device companies across 215 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Inklab is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice $4,351 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$4,351
Total received (2018-2024)
Avg $622/year across 7 years
Top 30% in WA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
215
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,905 (89.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$446 (10.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,195
2023
$562
2022
$664
2021
$1,524
2020
$121
2019
$214
2018
$71

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$146
AstraZeneca Pharmaceuticals LP
$107
Merck Sharp & Dohme LLC
$93
Regeneron Healthcare Solutions, Inc.
$62
Celgene Corporation
$59
Tactile Systems Technology Inc
$58
E.R. Squibb & Sons, L.L.C.
$53
Bayer Healthcare Pharmaceuticals Inc.
$53
Takeda Pharmaceuticals U.S.A., Inc.
$53
BeiGene USA, Inc.
$46
Janssen Biotech, Inc.
$42
ACCORD HEALTHCARE, INC.
$42
Mirati Therapeutics, Inc.
$40
SpringWorks Therapeutics, Inc.
$35
Lilly USA, LLC
$30
SOBI, INC
$28
GlaxoSmithKline, LLC.
$25
GENZYME CORPORATION
$24
Agios Pharmaceuticals, Inc.
$23
Boehringer Ingelheim Pharmaceuticals, Inc.
$23
Gilead Sciences, Inc.
$23
Daiichi Sankyo Inc.
$22
ADC Therapeutics America, Inc.
$21
EMD Serono, Inc.
$21
Incyte Corporation
$20
Exelixis Inc.
$17
ABBVIE INC.
$16
Alnylam Pharmaceuticals Inc.
$14
Top 3 companies account for 28.9% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$448
Novartis Pharmaceuticals Corporation
$316
Takeda Pharmaceuticals U.S.A., Inc.
$289
Janssen Biotech, Inc.
$279
Amgen Inc.
$275
Boehringer Ingelheim Pharmaceuticals, Inc.
$205
AstraZeneca Pharmaceuticals LP
$205
Merck Sharp & Dohme LLC
$182
Daiichi Sankyo Inc.
$147
GENZYME CORPORATION
$140
Celgene Corporation
$132
Regeneron Healthcare Solutions, Inc.
$114
BeiGene USA, Inc.
$101
Incyte Corporation
$98
Bayer HealthCare Pharmaceuticals Inc.
$89
Rigel Pharmaceuticals, Inc.
$87
Mirati Therapeutics, Inc.
$77
Bayer Healthcare Pharmaceuticals Inc.
$77
Lilly USA, LLC
$74
Merck Sharp & Dohme Corporation
$72
Kite Pharma, Inc.
$63
Tactile Systems Technology Inc
$58
Seagen Inc.
$56
EISAI INC.
$52
PFIZER INC.
$51
Myovant Sciences Inc.
$46
GlaxoSmithKline, LLC.
$44
ACCORD HEALTHCARE, INC.
$42
Acceleron Pharma, Inc.
$40
Exelixis Inc.
$39
SpringWorks Therapeutics, Inc.
$35
Gilead Sciences, Inc.
$35
AVEO Pharmaceuticals, Inc.
$31
SOBI, INC
$28
TerSera Therapeutics LLC
$26
Genentech USA, Inc.
$25
Servier Pharmaceuticals LLC
$24
Agios Pharmaceuticals, Inc.
$23
Foundation Medicine, Inc.
$23
ADC Therapeutics America, Inc.
$21
EMD Serono, Inc.
$21
Janssen Pharmaceuticals, Inc
$21
Myriad Genetic Laboratories, Inc.
$20
Astellas Pharma US Inc
$18
Eisai Inc.
$18
ABBVIE INC.
$16
SERVIER PHARMACEUTICALS LLC
$14
Teva Pharmaceuticals USA, Inc.
$14
Alnylam Pharmaceuticals Inc.
$14
Pharmacosmos Therapeutics Inc.
$12
AbbVie, Inc.
$11
Top 3 companies account for 24.2% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · ALUNBRIG · BENDEKA · BLENREP · BOSULIF · BRUKINSA · CABOMETYX · CALQUENCE · CAMCEVI · COSELA · DARZALEX · DISEASE STATE · DOPTELET · ELAHERE · ELITEK · ENHERTU · Enhertu · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Flexitouch Plus · GAZYVA · GILOTRIF · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · NINLARO · Nplate · Nubeqa · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · OXLUMO · PADCEV · PEMAZYRE · PLUVICTO · PROMACTA · PYRUKYND · Pomalyst · REBLOZYL · Reblozyl · SARCLISA · SCEMBLIX · Stivarga · TABRECTA · TASIGNA · TIBSOVO · Tavalisse · Trodelvy · VERZENIO · Venclexta · XARELTO · XGEVA · Xermelo · Xospata · Yescarta · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (90%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hematology & oncology specialist in Sunnyside?
Compare hematology & oncology specialists in the Sunnyside area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
1
Per 100K population
0.5
County median income
$87,316
Nearest hospital
ASTRIA SUNNYSIDE HOSPITAL
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Inklab is a hematology & oncology specialist, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Inklab receive payments from pharmaceutical companies?
Yes. Dr. Inklab received a total of $4,351 from 51 companies across 215 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Inklab) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Hematology & Oncology Specialists in Sunnyside
Browse hematology & oncology specialists in Sunnyside ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in WA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in WA
Which WA hematology & oncology specialists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →